The tortured road in the discovery and development of Fidaxomicin may shed some light on the obstacles that underline this truism. In the 1980s, the mantra for the discovery of new antibiotics was ...

Louie et al. [45] conducted a randomized, open-label study of the safety and efficacy of fidaxomicin in patients with mild-to-moderately severe CDI. Adults with three or more diarrheal stools ...

Am J Health Syst Pharm. 2012;69(11):933-943. Based on current clinical trials reporting fewer recurrences among patients treated with fidaxomicin in which the non-NAP1/BI/027 strains were isolated ...

The Institute for Quality and Efficiency in Health Care (IQWiG) has now assessed such additional information for two studies comparing the antibiotic fidaxomicin, which is used for diarrhoea ...

NEW YORK, Feb 7 (Reuters) - Optimer Pharmaceuticals Inc said it signed a licensing deal for its experimental antibiotic, fidaxomicin, with Japanese drugmaker Astellas Pharma Inc's <4503.T ...